semaglutide cardiac benefits Cardiovascular outcomes of and tirzepatide for patients with type 2 diabetes in clinical practice New Science Suggests Semaglutide Improves

In a November 2024 article featured in The New England Journal of Medicine, researchers found that tirzepatide reduced the risk of cardiovascular death or worsening heart failure in patients with heart failure with preserved ejection fraction and obesity

GLP-1 (glucagon-like peptide-1) receptor agonists have gained popularity as an effective treatment for weight loss and diabetes management

doi: 10.3390/ijms222111430

Do not reuse needles

This precision-wellness approach empowers informed decision-making about initiation, dose adjustment, or alternative GLP-1 therapiesensuring treatment aligns with your body's biological context

Over the years, she successfully fought to have her name included in GLP-1 patents as a co-inventor and corrected papers in high-profile journals that omitted her findings